Literature DB >> 868905

Ototoxicity and nephrotoxicity of amikacin: an overview of phase II and phase III experience in the United States.

A Z Lane, G E Wright, D C Blair.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 868905     DOI： 10.1016/0002-9343(77)90660-x

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  12 in total

1.  Precautionary Practices of Respiratory Therapists and Other Health-Care Practitioners Who Administer Aerosolized Medications.

Authors:  Rebecca J Tsai; James M Boiano; Andrea L Steege; Marie H Sweeney
Journal:  Respir Care       Date:  2015-07-07       Impact factor: 2.258

2.  ER-mitochondrial calcium flow underlies vulnerability of mechanosensory hair cells to damage.

Authors:  Robert Esterberg; Dale W Hailey; Edwin W Rubel; David W Raible
Journal:  J Neurosci       Date:  2014-07-16       Impact factor: 6.167

3.  Tobramycin nephrotoxicity. A prospective clinical study.

Authors:  A Coca; J Blade; A Martinez; F Segura; E Soriano; M Ribas-Mundo
Journal:  Postgrad Med J       Date:  1979-11       Impact factor: 2.401

4.  Prospective, randomized trial of netilmicin and amikacin, with emphasis on eighth-nerve toxicity.

Authors:  M Barza; M W Lauermann; F P Tally; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

5.  Risk factors for toxicity in elderly patients given aminoglycosides once daily.

Authors:  D L Paterson; J M Robson; M M Wagener
Journal:  J Gen Intern Med       Date:  1998-11       Impact factor: 5.128

Review 6.  Sisomicin, netilmicin and dibekacin. A review of their antibacterial activity and therapeutic use.

Authors:  P Noone
Journal:  Drugs       Date:  1984-06       Impact factor: 9.546

7.  [Clinical efficacy, nephrotoxicity and ototoxicity of amikacin].

Authors:  P Federspil; K Schindler; C Weich; E Tiesler; W Schätzle; M Ziegler
Journal:  Infection       Date:  1979       Impact factor: 3.553

8.  Comparison of the nephrotoxicity and auditory toxicity of tobramycin and amikacin.

Authors:  J M Gatell; J G San Miguel; L Zamora; V Araujo; M Bonet; M Bohé; M T Jimenez de Anta; M Farré; M Elena; A Ballesta; J L Marin
Journal:  Antimicrob Agents Chemother       Date:  1983-06       Impact factor: 5.191

Review 9.  Identification of impaired hearing in early childhood.

Authors:  D Wong; C P Shah
Journal:  Can Med Assoc J       Date:  1979-09-08       Impact factor: 8.262

10.  Prevalence and risk factors for aminoglycoside nephrotoxicity in intensive care units.

Authors:  João F P Oliveira; Carolina A Silva; Camila D Barbieri; Giselle M Oliveira; Dirce M T Zanetta; Emmanuel A Burdmann
Journal:  Antimicrob Agents Chemother       Date:  2009-04-13       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.